Record 10-year SBRT study among low-risk patients

Alan Katz has now published the study with the longest-running follow-up of any study of external beam radiation therapy for prostate cancer among low-risk patients, in this case using SBRT. … READ MORE …

A new 10-year mortality estimator — and its potential utility

As we age, and have to consider the risks and benefits of all sorts of health-related issues, it is often both helpful and important to have a clear and reasonable idea of how long we might expect to live. … READ MORE …

Age at treatment does not appear to affect outcome after brachytherapy

A Dutch research group has compared survival after prostate brachytherapy in two sets of patients, one aged ≤ 60 years at time of treatment and the other aged >60 years. … READ MORE …